Status:
COMPLETED
Observational Study of Patients With Diabetes Using Levemir® FlexPen®
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Diabetes
Diabetes Mellitus, Type 1
Eligibility:
All Genders
Brief Summary
This study is conducted in Asia. This study is a prospective, open, uncontrolled, observational surveillance study with Levemir® FlexPen® conducted in Korea. The aim of this observational study is to...
Eligibility Criteria
Inclusion
- Diabetes Mellitus
Exclusion
- Contra-indication based on local label
Key Trial Info
Start Date :
July 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2009
Estimated Enrollment :
797 Patients enrolled
Trial Details
Trial ID
NCT00670683
Start Date
July 1 2007
End Date
September 1 2009
Last Update
March 3 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pusan, South Korea, 602-739